Karriereverlauf von Thamil Annamalai
Ehemalige bekannte Positionen von Thamil Annamalai
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2014 | 01.01.2017 |
| XENOPORT, INC. | Direktor/Vorstandsmitglied | 01.01.2001 | 01.01.2013 |
IntraBiotics Pharmaceuticals, Inc.
 IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | Corporate Officer/Principal | 01.01.1997 | - |
Essential Therapeutics, Inc.
 Essential Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Essential Therapeutics, Inc. manufactures pharmaceutical goods for viral and fungal infections | Corporate Officer/Principal | 01.01.1994 | - |
| Nycomed Salutar, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1991 | 01.01.1994 |
Ausbildung von Thamil Annamalai
| University of Madras | Graduate Degree |
| Pachaiyappas College | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Indien | 3 |
Operativ
| Corporate Officer/Principal | 3 |
| Graduate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
IntraBiotics Pharmaceuticals, Inc.
IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | Health Technology |
Essential Therapeutics, Inc.
Essential Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Essential Therapeutics, Inc. manufactures pharmaceutical goods for viral and fungal infections | Health Technology |
| Nycomed Salutar, Inc. | |
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
- Börse
- Insiders
- Thamil Annamalai
- Erfahrung